134 related articles for article (PubMed ID: 2771203)
1. Altered lipofuscin pigmentation in the basal nucleus (Meynert) in Parkinson's disease.
Ulfig N
Neurosci Res; 1989 Jun; 6(5):456-62. PubMed ID: 2771203
[TBL] [Abstract][Full Text] [Related]
2. Changes within the basal nucleus in Parkinson's disease.
Ulfig N; Braak E; Braak H
Prog Clin Biol Res; 1989; 317():493-500. PubMed ID: 2690110
[TBL] [Abstract][Full Text] [Related]
3. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment.
Mann DM; Yates PO; Marcyniuk B
Mech Ageing Dev; 1984; 25(1-2):189-204. PubMed ID: 6202988
[TBL] [Abstract][Full Text] [Related]
4. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
Chan-Palay V
Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477
[No Abstract] [Full Text] [Related]
5. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease--a quantitative Golgi investigation.
Arendt T; Zvegintseva HG; Leontovich TA
Neuroscience; 1986 Dec; 19(4):1265-78. PubMed ID: 3822121
[TBL] [Abstract][Full Text] [Related]
6. Neuronal types and their percent distribution within the magnocellular nuclei of the human basal forebrain.
Ulfig N; Braak H
Acta Anat (Basel); 1989; 134(3):237-41. PubMed ID: 2543182
[TBL] [Abstract][Full Text] [Related]
7. Configuration of the magnocellular nuclei in the basal forebrain of the human adult.
Ulfig N
Acta Anat (Basel); 1989; 134(2):100-5. PubMed ID: 2718722
[TBL] [Abstract][Full Text] [Related]
8. Distribution of intracytoplasmic acidophilic granules in the magnocellular nuclei of the basal forebrain in normal individuals and patients suffering from Parkinson's disease.
Ulfig N
Clin Neuropathol; 1991; 10(1):11-5. PubMed ID: 2015721
[TBL] [Abstract][Full Text] [Related]
9. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
10. The basal nucleus of Meynert in idiopathic Parkinson's disease.
Tagliavini F; Pilleri G; Bouras C; Constantinidis J
Acta Neurol Scand; 1984 Jul; 70(1):20-8. PubMed ID: 6475484
[TBL] [Abstract][Full Text] [Related]
11. Electron-microscopic observation of the nucleus basilis of Meynert in human autopsy cases.
Morimura Y; Hirano A; Llena JF
Acta Neuropathol; 1985; 68(2):130-7. PubMed ID: 3000126
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
Nakano I; Hirano A
Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
[TBL] [Abstract][Full Text] [Related]
13. The nucleus basalis of Meynert.
Ezrin-Waters C; Resch L
Can J Neurol Sci; 1986 Feb; 13(1):8-14. PubMed ID: 2937514
[TBL] [Abstract][Full Text] [Related]
14. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
Kowall NW; Beal MF
Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic demonstration of 5HT1 binding sites in the primate basal nucleus of Meynert.
Mitchell IJ; Stuart AM; Slater P; Unwin HP; Crossman AR
Eur J Pharmacol; 1984 Sep; 104(1-2):189-90. PubMed ID: 6499916
[No Abstract] [Full Text] [Related]
16. Distribution of beta-nerve growth factor receptors in the human basal forebrain.
Allen SJ; Dawbarn D; Spillantini MG; Goedert M; Wilcock GK; Moss TH; Semenenko FM
J Comp Neurol; 1989 Nov; 289(4):626-40. PubMed ID: 2556457
[TBL] [Abstract][Full Text] [Related]
17. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
18. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
Gerlach M; Gsell W; Kornhuber J; Jellinger K; Krieger V; Pantucek F; Vock R; Riederer P
Brain Res; 1996 Nov; 741(1-2):142-52. PubMed ID: 9001716
[TBL] [Abstract][Full Text] [Related]
19. Excitatory amino acid uptake sites in the human nucleus of Meynert.
Charlton FA; Candy JM
Eur J Pharmacol; 1988 Jun; 151(1):163-4. PubMed ID: 2843388
[No Abstract] [Full Text] [Related]
20. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia.
Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Iizuka R
Brain Res; 1989 Oct; 499(2):402-6. PubMed ID: 2804687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
